Q-omics provides the consensus-scored RBM22P7 profile across patient tissues and cancer cell-line models. RBM22P7 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RBM22P7 RNA expression shows 5,253 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight BLCA, and STAD as cancer lineages where RBM22P7 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RBM22P7 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RBM22P7 survival associations across molecular data types. RBM22P7 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RBM22P7 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	BLCA (144)	view →

This table ranks reproducible RBM22P7 RNA expression–survival associations across cancer types. High RBM22P7 expression shows unfavorable associations in BLCA, SKCM, UCEC, ESCA, STAD and LAML. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for RBM22P7 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.051	0.720	<.001	144	view →
SKCM	DFS	Tertile	II,III,IV	0.029	0.691	<.001	72	view →
UCEC	OS	Tertile	II,III,IV	0.644	0.855	.024	42	view →
ESCA	OS	Tertile	All	0.257	0.568	.007	36	view →
STAD	OS	Tertile	IV	0.075	0.496	.013	18	view →
LAML	DFS	Tertile	All	0.221	0.587	.049	18	view →

Pink = unfavorable, green = favorable. all 7 lineages →

RBM22P7-BLCA (OS)

Kaplan–Meier survival curve for RBM22P7 RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RBM22P7 in patient tissues and cancer cell lines. In patient samples, RBM22P7 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,253	STAD (5180)	view →
RNA	4,260	LUSC (1930)	view →